Myelodysplastic Syndrome Clinical Trials 2022

Browse 201 Myelodysplastic Syndrome Medical Studies Across 353 Cities

17 Phase 3 Trial · 1411 Myelodysplastic Syndrome Clinics

Reviewed by Michael Gill, B. Sc.
25 Myelodysplastic Syndrome Clinical Trials Near Me
Rochester, NY
Bronx, NY
Indianapolis, IN
Stanford, CA
More Trial Locations
An interactive map to display trial locations for University of Rochester, Montefiore Einstein Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Stanford University, and 119 more locations.
Most Popular References for Myelodysplastic Syndrome Clinical Trials
Frequency
Citation
Top Hospitals for Myelodysplastic Syndrome Clinical Trials
Location
Active Myelodysplastic Syndrome Clinical Trials
All Time Trials for Myelodysplastic Syndrome
First Recorded Myelodysplastic Syndrome Trial
Trials
Washington University School of Medicine, Saint Louis, Missouri
12
37
2003
Top Cities for Myelodysplastic Syndrome Clinical Trials
Which phases are most popular for myelodysplastic syndrome clinical trials?
Most Recent Myelodysplastic Syndrome Clinical Trials
Phase 3 Myelodysplastic Syndrome Clinical Trials
Senior Friendly Myelodysplastic Syndrome Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Myelodysplastic Syndrome
Treatment
Year
Mechanism of Action
Sponsor
Active Myelodysplastic Syndrome Clinical Trials
TP-0184
2020
Sumitomo Pharma Oncology, Inc.
0
Pevonedistat
2019
Pevonedistat
Millennium Pharmaceuticals, Inc.
4
JNJ-67571244
2019
Janssen Research & Development, LLC
0
Pevonedistat
2018
Pevonedistat
Justin Watts, MD
4
Unmanipulated Umbilical Cord Blood (UCB)
2018
Angiocrine Bioscience
0
ASTX727
2018
Decitabine + Cedazuridine
Astex Pharmaceuticals, Inc.
23

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 6th, 2021

Last Reviewed: August 19th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.